| Date Filed | Type | Description |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/14/2023 |
8-K
| Quarterly results |
| 06/02/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 06/01/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/11/2023 |
SC 13G
| LYTTON LAURENCE W reports a 5.1% stake in Miromatrix Medical Inc. |
| 05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/11/2023 |
8-K
| Quarterly results |
| 04/18/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/18/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/31/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/31/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 03/09/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 03/08/2023 |
8-K
| Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Regulation FD Disclosure, Other Ev... |
| 03/07/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 02/06/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/01/2023 |
8-K
| Quarterly results |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 12/14/2022 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
| 12/08/2022 |
4
| Ross Jeffrey James (CEO) has filed a Form 4 on Miromatrix Medical Inc.|
Txns:
| Paid exercise price by delivering 11,575 shares
@ $4.05, valued at
$46.9k
Exercised 37,500 options to buy
@ $1.25, valued at
$46.9k
|
|
| 10/04/2022 |
4
| Barry John Joseph (VICE PRESIDENT OF R&D) has filed a Form 4 on Miromatrix Medical Inc.|
Txns:
| Paid exercise price by delivering 765 shares
@ $4.38, valued at
$3.4k
|
|
| 08/16/2022 |
4
| BUCKMAN PAUL (Director) has filed a Form 4 on Miromatrix Medical Inc.|
Txns:
| Granted 12,788 shares
@ $0 |
|
| 08/16/2022 |
4
| Maag Peter (Director) has filed a Form 4 on Miromatrix Medical Inc.|
Txns:
| Granted 12,788 shares
@ $0 |
|
| 08/16/2022 |
4
| Heine Lisa Wipperman (Director) has filed a Form 4 on Miromatrix Medical Inc.|
Txns:
| Granted 12,788 shares
@ $0 |
|
| 08/16/2022 |
4
| Burke William P. Mr. (Director) has filed a Form 4 on Miromatrix Medical Inc.|
Txns:
| Granted 12,788 shares
@ $0 |
|
| 08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2022 |
8-K
| Quarterly results |
| 08/15/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 07/12/2022 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 07/12/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 07/01/2022 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 06/02/2022 |
8-K
| Quarterly results |
|